Conference Activities & Talks -

Division display  1 - 20 of about 192 ／  All the affair displays >>

  1. Tsuji K, Huang X, Kobayakawa T, Burke TR Jr., Tamamura H. Development of high-affinity polo-like kinase 1 polo-box domain binding peptides by bivalent approaches. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  2. Huang X, Tsuji K, KobayakawaT, Tamamura H. Investigation on degrader peptides targeting the polo-box domain for degradation of polo-like kinase 1. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  3. Yamamoto K, Kobayakawa T, Tsuji K, Tamamura H. Development of chloroalkene-type dipeptide isosteres for amyloid-beta aggregation inhibitors. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  4. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. Structure-activity relationship studies of novel SARS-CoV-2 papain-like protease inhibitors and their application as anti-Mpox agents. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  5. Tamamura H. New horizon of drug discovery for anti-HIV drugs. The 82nd FIP World Congress of Pharmacy and Pharmaceutical Sciences, HIV treatment: the future of preventative care and management 2024.09.01 Cape Town, South Africa

  6. Tamamura H. Development of anti-HIV agents targeting HIV-Gag proteins using in silico screening . The 37th European Peptide Symposium (EPS) & 14th International Peptide Symposium (IPS) Satellite Workshops, Applications of computational AI/ML in peptide research with a roadmap to peptide drug and material development 2024.08.30 Florence, Italy

  7. Kobayakawa T, Azuma C, Yamamoto K , Tsuji K, Tamamura H. Convergent synthesis of peptidomimetic based on a chloroalkene dipeptide isostere and its application to inhibition against amyloid β aggregation. 14th International Peptide Symposium 2024.08.26 Florence, Italy

  8. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Development of antibody drug conjugates as HIV entry inhibitors. 37th European peptide symposium 2024.08.26 Florence, Italy

  9. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Development of hybrid-molecules as HIV entry inhibitors. 18th Chinese international peptide symposium 2024.07.01 Hong Kong

  10. Tamamura H. Tripeptide-mimic Inhibitors against a Main Protease of SARS-CoV-2. The 18th Chinese International Peptide Symposium 2024.06.30 Hong Kong

  11. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Antibody drug conjugates as HIV entry inhibitors. 27th Korean Peptide Protein Symposium 2024.06.24 Busan, South Korea

  12. Tamamura H. Medicinal chemistry derived from peptides and peptidomimetics. The 10th Joint Symposium between IBB/TMDU and Chulalongkorn University on Biomedical Materials and Engineering 2024.01.19 Thailand

  13. Takuya Kobayakawa, Chika Azuma, Kenichi Yamamoto, Kohei Tsuji, Hirokazu Tamamura. Development of synthetic strategies for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 15th International Kyoto Conference on New Aspects of Organic Chemistry 2023.11.21 Kyoto

  14. Kohei Tsuji, Hirokazu Tamamura, Terrence R. Burke, Jr.. Utilization of a non-specific kinase inhibitor for the development of high-affinity bivalent polo-like kinase 1 polo-box domain inhibitors. The 60th Japanese Peptide Symposium 2023.11.10 Otsu

  15. Takuya Kobayakawa, Chika Azuma, Kenichi Yamamoto, Kohei Tsuji, Hirokazu Tamamura. Development of convergent synthesis for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 60th Japanese Peptide Symposium 2023.11.08 Otsu

  16. Kouki Shinohara, Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Yutaro Miura, Chika Azuma, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Structure-activity relationship studies of novel SARS-CoV-2 main protease inhibitors with potent antiviral activity. The 60th Japanese Peptide Symposium 2023.11.08 Otsu

  17. Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Combinational use of CD4 mimic with other anti-HIV agents and development of these hybrid molecules. 14th International Peptide Symposium 2023.10.17 Brisbane

  18. Hirokazu Tamamura. Anti-SARS-CoV-2 Agents Inspired from HIV Researches. The 13th International Peptide Symposium/The 15th Australian Peptide Conference 2023.10.17 Brisbane

  19. Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Double target inhibitors of HIV-1 entry based on hybrid molecules of CD4 mimics and HIV-1 gp41-related peptides. 26th Korean Peptide Protein Symposium 2023.07.04 Jeju

  20. Takahiro Ishii, Kohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Kouki Shinohara, Yutaro Miura, Hironori Hayashi, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura . Design and Synthesis of SARS-CoV-2 Mpro Inhibitors Containing Flurine Atoms and Amide Surrogates. 26th KPPS Annual Symposium 2023.07.03 Jeju

< PREV - NEXT >

To the head of this page.▲